The first pill shown to treat COVID-19 has moved one step closer to being available to the public. The pharmaceutical company Merck requested FDA emergency authorization Monday for their COVID-19 ...

WASHINGTON (AP) — Pfizer received full approval on Thursday for its COVID-19 pill Paxlovid that’s been the go-to treatment against the coronavirus. More than 11 million prescriptions for Paxlovid have ...

Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental COVID-19 pill. The agreement with the Medicines Patent Pool, a United Nations-backed public ...

LONDON - Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more ...

AUTOWORKERS. FIVE ON YOUR HEALTH. TONIGHT, THERE’S A NEW STUDY THAT SUGGESTS A POPULAR PILL THAT’S USED TO TREAT COVID COULD CREATE MUTATIONS THAT WILL THEN SPREAD IT TO OTHER PEOPLE. HERE TO TALK ...

Pfizer stock slumped Tuesday as the pharmaceutical giant said it expects sales for its Covid-19 vaccine and oral treatment to decline significantly this year, as investors digest a shifting reality ...

In issuing a positive recommendation, the EMA has diverged from the FDA, which has set higher approval standards for ...

WASHINGTON — Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisors Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration.

Add Yahoo as a preferred source to see more of our stories on Google. By now, most people have reached a resigned acceptance when it comes to COVID-19. We accept that we’re probably going to get ...